<?xml version="1.0" encoding="UTF-8"?>
<p>At the end of 2019, a cluster of pneumonia patients were confirmed to be infected with a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), in Wuhan, Hubei Province, China. This infectious disease was designated as coronavirus disease 2019 (COVID‐19). It rapidly spreads throughout the world. More than 80 000 cases have been reported in China and epidemics have grown in other countries.
 <xref rid="hae14000-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref> However, minimal information is available regarding COVID‐19 patients with haemophilia A. Herein, we retrospectively analysed the epidemiological, clinical, laboratory and radiological characteristics, treatment and clinical outcomes of an infected patient with haemophilia A in Wuhan. This case report may be a good example for the management of mild COVID‐19 cases with haemophilia A.
</p>
